P L Mai1, L Wideroff, M H Greene, B I Graubard. 1. Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20852, USA. maip@mail.nih.gov
Abstract
BACKGROUND: A positive family history is a known risk factor for several cancers; thus, obtaining a thorough family cancer history is essential in cancer risk evaluation and prevention management. METHODS: The Family Health Study, a telephone survey in Connecticut, was conducted in 2001. A total of 1,019 participants with demographic information and family cancer history were included in this study. Prevalence of a positive family history of breast, colorectal, prostate, and lung cancer for first- and second-degree relatives was estimated. Logistic regression was used to compare prevalence by demographic factors. RESULTS: A positive family history among first-degree relatives was reported by 10.9% (95% Confidence Interval, CI = 8.8-13.3) of respondents for breast cancer, 5.1% (95% CI = 3.9-6.7) for colorectal cancer, 7.0% (95% CI = 5.2-9.4) for prostate cancer, and 6.4% (95% CI = 4.9-8.3) for lung cancer. The reported prevalence of family history of specific cancers varied by sex, age and race/ethnicity of the respondents. CONCLUSION: Family history prevalence for 4 of the most common adult solid tumors is substantial and the reported prevalence varied by respondent characteristics. Additional studies are needed to evaluate tools to promote accurate reporting of family history of cancer.
BACKGROUND: A positive family history is a known risk factor for several cancers; thus, obtaining a thorough family cancer history is essential in cancer risk evaluation and prevention management. METHODS: The Family Health Study, a telephone survey in Connecticut, was conducted in 2001. A total of 1,019 participants with demographic information and family cancer history were included in this study. Prevalence of a positive family history of breast, colorectal, prostate, and lung cancer for first- and second-degree relatives was estimated. Logistic regression was used to compare prevalence by demographic factors. RESULTS: A positive family history among first-degree relatives was reported by 10.9% (95% Confidence Interval, CI = 8.8-13.3) of respondents for breast cancer, 5.1% (95% CI = 3.9-6.7) for colorectal cancer, 7.0% (95% CI = 5.2-9.4) for prostate cancer, and 6.4% (95% CI = 4.9-8.3) for lung cancer. The reported prevalence of family history of specific cancers varied by sex, age and race/ethnicity of the respondents. CONCLUSION: Family history prevalence for 4 of the most common adult solid tumors is substantial and the reported prevalence varied by respondent characteristics. Additional studies are needed to evaluate tools to promote accurate reporting of family history of cancer.
Authors: Paula W Yoon; Maren T Scheuner; Kris L Peterson-Oehlke; Marta Gwinn; Andrew Faucett; Muin J Khoury Journal: Genet Med Date: 2002 Jul-Aug Impact factor: 8.822
Authors: Esther M John; Alison J Canchola; Meera Sangaramoorthy; Jocelyn Koo; Alice S Whittemore; Dee W West Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-09-05 Impact factor: 4.254
Authors: Traci N Bethea; Lynn Rosenberg; Nelsy Castro-Webb; Kathryn L Lunetta; Lara E Sucheston-Campbell; Edward A Ruiz-Narváez; Marjory Charlot; Song-Yi Park; Elisa V Bandera; Melissa A Troester; Christine B Ambrosone; Julie R Palmer Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-12-31 Impact factor: 4.254
Authors: Elissa M Ozanne; Adrienne O'Connell; Colleen Bouzan; Phil Bosinoff; Taryn Rourke; Dana Dowd; Brian Drohan; Fred Millham; Pat Griffin; Elkan F Halpern; Alan Semine; Kevin S Hughes Journal: J Genet Couns Date: 2012-01-12 Impact factor: 2.537
Authors: Mary K Schubauer-Berigan; Jeri L Anderson; Misty J Hein; Mark P Little; Alice J Sigurdson; Lynne E Pinkerton Journal: Am J Ind Med Date: 2015-03 Impact factor: 2.214
Authors: Hannah Oh; Clara Bodelon; Maya Palakal; Nilanjan Chatterjee; Mark E Sherman; Laura Linville; Berta M Geller; Pamela M Vacek; Donald L Weaver; Rachael E Chicoine; Daphne Papathomas; Deesha A Patel; Jackie Xiang; Susan E Clare; Daniel W Visscher; Carolyn Mies; Stephen M Hewitt; Louise A Brinton; Anna Maria V Storniolo; Chunyan He; Montserrat Garcia-Closas; Stephen J Chanock; Gretchen L Gierach; Jonine D Figueroa Journal: Breast Cancer Res Treat Date: 2016-06-24 Impact factor: 4.872
Authors: Marco Randazzo; Alexander Müller; Sigrid Carlsson; Daniel Eberli; Andreas Huber; Rainer Grobholz; Lukas Manka; Ashkan Mortezavi; Tullio Sulser; Franz Recker; Maciej Kwiatkowski Journal: BJU Int Date: 2015-10-06 Impact factor: 5.588
Authors: Jan T Lowery; Dennis J Ahnen; Paul C Schroy; Heather Hampel; Nancy Baxter; C Richard Boland; Randall W Burt; Lynn Butterly; Megan Doerr; Mary Doroshenk; W Gregory Feero; Nora Henrikson; Uri Ladabaum; David Lieberman; Elizabeth G McFarland; Susan K Peterson; Martha Raymond; N Jewel Samadder; Sapna Syngal; Thomas K Weber; Ann G Zauber; Robert Smith Journal: Cancer Date: 2016-06-03 Impact factor: 6.860